- Home
- PD vs BCRX Comparison
PD vs BCRX Comparison
Compare PD & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PD
- BCRX
- Stock Information
- Founded
- PD 2009
- BCRX 1986
- Country
- PD United States
- BCRX United States
- Employees
- PD N/A
- BCRX N/A
- Industry
- PD Computer Software: Prepackaged Software
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PD Technology
- BCRX Health Care
- Exchange
- PD Nasdaq
- BCRX Nasdaq
- Market Cap
- PD 1.5B
- BCRX 1.4B
- IPO Year
- PD 2019
- BCRX 1994
- Fundamental
- Price
- PD $15.76
- BCRX $7.31
- Analyst Decision
- PD Hold
- BCRX Strong Buy
- Analyst Count
- PD 9
- BCRX 11
- Target Price
- PD $18.33
- BCRX $19.55
- AVG Volume (30 Days)
- PD 2.0M
- BCRX 7.0M
- Earning Date
- PD 11-25-2025
- BCRX 11-03-2025
- Dividend Yield
- PD N/A
- BCRX N/A
- EPS Growth
- PD N/A
- BCRX N/A
- EPS
- PD N/A
- BCRX N/A
- Revenue
- PD $483,608,000.00
- BCRX $557,506,000.00
- Revenue This Year
- PD $9.16
- BCRX $41.57
- Revenue Next Year
- PD $6.79
- BCRX $6.25
- P/E Ratio
- PD N/A
- BCRX N/A
- Revenue Growth
- PD 8.20
- BCRX 45.85
- 52 Week Low
- PD $13.70
- BCRX $6.00
- 52 Week High
- PD $21.98
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- PD 44.59
- BCRX 51.20
- Support Level
- PD $15.50
- BCRX $6.44
- Resistance Level
- PD $16.40
- BCRX $6.92
- Average True Range (ATR)
- PD 0.40
- BCRX 0.30
- MACD
- PD 0.00
- BCRX 0.09
- Stochastic Oscillator
- PD 27.53
- BCRX 95.62
About PD PagerDuty Inc.
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.